Fully liquid DTaP-IPV-Hib pediatric combination vaccine (Pediacel): a review of 18 years of clinical experience

被引:7
作者
Reynolds, Donna L. [1 ]
Vidor, Emmanuel [2 ]
机构
[1] Univ Toronto, Toronto, ON, Canada
[2] Sanofi Pasteur, Global Med Affairs, F-69367 Lyon, France
关键词
effectiveness; efficacy; immunogenicity; Pediacel((R)); pediatric combination vaccine; pentavalent; public health; safety; INFLUENZAE TYPE-B; C CONJUGATE VACCINE; 5-COMPONENT ACELLULAR PERTUSSIS; INACTIVATED POLIOMYELITIS; ANTIBODY PERSISTENCE; PNEUMOCOCCAL VACCINE; PRIMARY SERIES; DOUBLE-BLIND; PHASE-III; T VACCINE;
D O I
10.1586/14760584.2014.933674
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Safe and effective combination pediatric vaccines are necessary to simplify complex immunization schedules and to improve coverage and protection for children worldwide. We provide an overview of the 18 years of clinical and worldwide experience with DTaP-IPV-Hib (Pediacel((R))), a unique fully liquid pentavalent vaccine (diphtheria [D], tetanus [T], acellular pertussis, inactivated poliovirus [IPV], Haemophilus influenzae type b [Hib]). Pediacel has demonstrated good and lasting immunogenicity in many populations, with differing primary series and booster schedules, and with a variety of coadministered vaccines. The acellular pertussis antigens have proven efficacy and real-world effectiveness. Clinical and post-marketing studies confirm the safety of Pediacel. Pediacel can be used for primary series and toddler booster doses, as well as in mixed pediatric vaccine schedules.
引用
收藏
页码:943 / 968
页数:26
相关论文
共 46 条
[1]   Post-licensure comparison of the safety profile of diphtheria/tetanus/whole cell pertussis/haemophilus influenza type b vaccine and a 5-in-1 diphtheria/tetanus/acellular pertussis/haemophilus influenza type b/polio vaccine in the United Kingdom [J].
Andrews, Nick ;
Stowe, Julia ;
Wise, Lesley ;
Miller, Elizabeth .
VACCINE, 2010, 28 (44) :7215-7220
[2]  
[Anonymous], 1999, MMWR Recomm Rep, V48, P1
[3]  
[Anonymous], VACCINES
[4]  
[Anonymous], 2012, Vaccines
[5]  
[Anonymous], VACCINES
[6]   Safety and immunogenicity of fully liquid DTaP5-IPV-Hib pediatric combination vaccine (Pediacel®) compared to DTaP3-HBV-IPV/Hib (Infanrix® Hexa) when coadministered with heptavalent pneumococcal conjugate vaccine (PCV7) as a booster at 11-18 months of age: A phase III, modified double-blind, randomized, controlled, multicenter study [J].
Berner, Reinhard ;
Boisnard, Florence ;
Thomas, Stephane ;
Mwawasi, Grace ;
Reynolds, Donna .
VACCINE, 2012, 30 (35) :5270-5277
[7]   A combined diphtheria, tetanus, five-component acellular pertussis, poliovirus and Haemophilus influenzae type b vaccine [J].
Black, Steven ;
Greenberg, David P. .
EXPERT REVIEW OF VACCINES, 2005, 4 (06) :793-805
[8]  
Capeding MR, 2002, PEDIATR INFECT DIS J
[9]  
Castaneda JL, 2004, ENHANCED INACTIVATED
[10]  
Castaneda JL, 2004, IMMUNOGENICITY SAFET